15 reports

Global Tendencies in Use of Antirheumatics ##. ## Trail from Conventional to Biological DMARDs ##. ## Global Trends of Antirheumatic Prescription ##.

  • Anti Rheumatic
  • Arthritis
  • Chronic Disease
  • Therapy
  • World

In more severe cases disease modifying anti-rheumatic drugs (DMARDs) may be prescribed.

  • Anti Rheumatic
  • Pathology
  • Therapy
  • United States
  • World

The initial treatment option is disease-modifying antirheumatic drugs, also known as DMARDs.

  • Anti Rheumatic
  • Monoclonal Antibody
  • Therapy
  • United States
  • World

In moderate to severe cases the treatment involves disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (Rheumatrex®).

  • Anti Rheumatic
  • Monoclonal Antibody
  • Therapy
  • United States
  • World

Anti-rheumatic Drugs Analysis, by Region, 2013-2022 ($MN) Table ## Global Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN) Table ## Global Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($

  • Anti Rheumatic
  • Asia
  • North America
  • World
  • Market Size

Antirheumatic Drugs (DMARDs) An Efficacy and Safety Study of Tramadol/ Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs) GDCT## NCT##, CR##

  • Anti Rheumatic
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.

Anti-rheumatic Drugs (DMARDs) Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents with Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying

  • Anti Rheumatic
  • Cytokine
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.

Anti- Rheumatic Drug (DMARD), (SMP-## ## mg and ## mg Once Daily), Administered in Combination with Ongoing Methotrexate Treatment in Patients with Active Rheumatoid Arthritis Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment with SMP-## GDCT## NCT##

  • Anesthetics
  • Anti Rheumatic
  • Clinical Trial
  • World
  • Product Initiative

antirheumatic drug Helsinki University Central Hospital Foundation for Paediatric Research ## May 2003 ## Nov 2007 ## ## ## ## ## Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member ## or TNF a or TNF) Inhibitor Tumor Necrosis Factor (Cachectin or T

  • Anti Rheumatic
  • Arthritis
  • Monoclonal Antibody
  • World
  • Product Initiative
  • 4.1 Changes to Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs, 2015-2022
  • 5.1 Abbreviations
  • Anti Rheumatic
  • Therapy
  • Japan
  • Clinical Trial profile. 73 Trial Title
  • Anti Rheumatic
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

The Impact of Antirheumatic Treatment on Antibody Response and Protection of Infections (Vaccimil) Vaccination in Inflammatory Rheumatic Disease (VACCIMIL).

  • Anti Rheumatic
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative

Anti-rheumatic Study of Association of Anti-inflammatory and Anti-rheumatic (ZDPC##) GDCT## NCT##, Musculoskeletal Disorders Osteoarthritis Planned Phase III Interventional Dinaflex; meloxicam Zodiac Produtos Farmaceuticos S. A.

  • Anti Rheumatic
  • Arthritis
  • Clinical Trial
  • World
  • Pfizer Inc.

antirheumatic drugs (DMARDs).

  • Anti Rheumatic
  • Musculoskeletal Disorder
  • Pharmaceutical
  • United States
  • Product Initiative

antirheumatic drugs (DMARDs).

  • Anti Rheumatic
  • Musculoskeletal Disorder
  • Pharmaceutical
  • United States
  • Product Initiative